279 related articles for article (PubMed ID: 15083501)
21. Pharmacokinetic changes of DA-7867, a new oxazolidinone, after intravenous and oral administration to rats with short-term and long-term diabetes mellitus induced by streptozotocin.
Bae SK; Yang SH; Lee SJ; Kwon JW; Kim WB; Lee DC; Lee MG
Eur J Pharm Sci; 2005 Jun; 25(2-3):337-45. PubMed ID: 15911231
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics and first-pass metabolism of astaxanthin in rats.
Choi HD; Kang HE; Yang SH; Lee MG; Shin WG
Br J Nutr; 2011 Jan; 105(2):220-7. PubMed ID: 20819240
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of DA-6034, an agent for inflammatory bowel disease, in rats and dogs: Contribution of intestinal first-pass effect to low bioavailability in rats.
Chung HJ; Choi YH; Choi HD; Jang JM; Shim HJ; Yoo M; Kwon JW; Lee MG
Eur J Pharm Sci; 2006 Mar; 27(4):363-74. PubMed ID: 16387482
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of intravenous and oral DA-8159, a new erectogenic, in rats with protein-calorie malnutrition.
Shim HJ; Kim YC; Lee JH; Ahn BO; Kwon JW; Kim WB; Lee I; Lee MG
J Pharm Pharmacol; 2004 Dec; 56(12):1543-50. PubMed ID: 15563761
[TBL] [Abstract][Full Text] [Related]
25. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
[TBL] [Abstract][Full Text] [Related]
26. Species differences in the formation of DA-8164 after intravenous and/or oral administration of DA-8159, a new erectogenic, to mice, rats, rabbits, dogs and humans.
Shim HJ; Kim YC; Lee JH; Park KJ; Kwon JW; Kim WB; Lee MG
Biopharm Drug Dispos; 2005 May; 26(4):161-6. PubMed ID: 15803515
[TBL] [Abstract][Full Text] [Related]
27. Subacute toxicities and toxicokinetics of DA-8159, a new phosphodiesterase type V inhibitor, after single and 4-week repeated oral administration in rats.
Shim HJ; Kim YC; Jang JM; Park KJ; Kim DH; Kang KK; Ahn BO; Kwon JW; Kim WB; Lee MG
Biopharm Drug Dispos; 2003 Dec; 24(9):409-18. PubMed ID: 14689469
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of oltipraz after intravenous and oral administration in rats with dehydration for 72 hours.
Bae SK; Lee SJ; Kim JW; Kim YH; Kim SG; Lee MG
Biopharm Drug Dispos; 2005 Mar; 26(2):77-83. PubMed ID: 15617135
[TBL] [Abstract][Full Text] [Related]
29. Stability, blood partition, and protein binding of a chemoprotective agent, 2-(allylthio)pyrazine.
Han KS; Woo SJ; Koo CH; Lee MG
Res Commun Mol Pathol Pharmacol; 1998 Aug; 101(2):171-8. PubMed ID: 9821213
[TBL] [Abstract][Full Text] [Related]
30. Effects of bacterial lipopolysaccharide on the pharmacokinetics of DA-7867, a new oxazolidinone, in rats.
Bae SK; Lee SJ; Kwon JW; Kim WB; Lee I; Lee MG
J Pharm Sci; 2004 Sep; 93(9):2364-73. PubMed ID: 15295796
[TBL] [Abstract][Full Text] [Related]
31. Uptake, distribution, and elimination of carbon tetrachloride in rat tissues following inhalation and ingestion exposures.
Sanzgiri UY; Srivatsan V; Muralidhara S; Dallas CE; Bruckner JV
Toxicol Appl Pharmacol; 1997 Mar; 143(1):120-9. PubMed ID: 9073600
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous and oral administration to rats: hepatic and gastric first-pass effects.
Han KS; Lee MG
Drug Metab Dispos; 1999 Feb; 27(2):221-6. PubMed ID: 9929506
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques.
Ramanathan-Girish S; Catz P; Creek MR; Wu B; Thomas D; Krogstad DJ; De D; Mirsalis JC; Green CE
Int J Toxicol; 2004; 23(3):179-89. PubMed ID: 15204721
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic changes of DA-8159, a new erectogenic, after intravenous and oral administration to rats with acute renal failure induced by uranyl nitrate.
Shim HJ; Kim YC; Kim EJ; Kim DG; Kwon JW; Kim WB; Lee MG
Biopharm Drug Dispos; 2004 Apr; 25(3):137-42. PubMed ID: 15083502
[TBL] [Abstract][Full Text] [Related]
35. Gender differences in the pharmacokinetics of DA-6034, a derivative of flavonoids, in rats.
Yang SH; Bae SK; Kwon JW; Yoo M; Lee MG
Biopharm Drug Dispos; 2006 Jan; 27(1):47-51. PubMed ID: 16302288
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of DA-8159, a new erectogenic, administered at 10:00 h versus 22:00 h in rats.
Lee JH; Kim YC; Kwon JW; Kim WB; Lee MG
Int J Pharm; 2005 May; 296(1-2):94-102. PubMed ID: 15885460
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic changes of oltipraz after intravenous and oral administration to rats with liver cirrhosis induced by dimethylnitrosamine.
Bae SK; Lee SJ; Lee JY; Lee Y; Lee I; Kim SG; Lee MG
Int J Pharm; 2004 May; 275(1-2):227-38. PubMed ID: 15081153
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic properties of TDP4815 after single intravenous and oral administrations to rat, rabbit, monkey, dog and in vitro drug metabolism.
Chen Y; Cheng D; Tio C; Kagan N; Eisennagel S; Dasgupta M; Tomczuk B; Bone R; Huebert N
Biopharm Drug Dispos; 2008 Apr; 29(3):127-38. PubMed ID: 18186144
[TBL] [Abstract][Full Text] [Related]
39. Dose-dependent pharmacokinetics of a new Na+/H+ exchanger inhibitor KR-33028 in rats.
Kim YH; Yoo SD; Kim YS; Lee KH; Lee HS
Biopharm Drug Dispos; 2007 Nov; 28(8):423-9. PubMed ID: 17828714
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of recombinant human erythropoietin in rabbits and 3/4 nephrectomized rats.
Yoon WH; Park SJ; Kim IC; Lee MG
Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):227-40. PubMed ID: 9226757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]